The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.

The menopause transition is often accompanied by a wide array of symptoms, some of which receive more attention than others.

STRESS URINARY INCONTINENCE. WHERE THE URETHRA, WHICH IS THE TUBE THAT URINE COMES OUT OF WHEN THE BLADDER SQUEEZES TO CONTRACT TO EMPTY THAT URETHRA DOESN’T CLOSE WHEN YOUR BLADDER IS SQUEEZING ...

Cretostimogene grenadenorepvec is an investigational oncolytic immunotherapy that is being studied for the treatment of bladder cancer, particularly non-muscle invasive bladder cancer (NMIBC) that is ...

Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.

The most common grade ≥3 TRAEs were urinary tract pain (4.7%), bladder pain (2.4%), and urinary tract infection (1.2%). Only three patients discontinued treatment because of TRAEs. Device ...

BOND-003 evaluated the efficacy and safety of cretostimogene grenadenorepvec, an oncolytic immunotherapy, in patients with carcinoma in situ BCG-unresponsive NMIBC.

for the treatment of adult patients with certain types of metastatic bladder or urinary tract cancer. Following a consultation with the US Food and Drug Administration (FDA), and in accordance ...

A weak flow and feeling as though your bladder hasn't completely emptied can also be indicative of a problem. Dr Kubes advised: "Any changes in urinary habits that are unusual for you should be ...

The most common urinary symptoms reflect urinary tract instrumentation effects, such as bladder spasm, burning sensation, and urinary tract infection. Most bladder irritations resolved shortly ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically ...